Results 51 to 60 of about 59,855 (258)
Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu +13 more
wiley +1 more source
Improvement of tardive dyskinesia after switching from zuclopenthixol decanoate to paliperidone palmitate: a case report [PDF]
Long-acting injectable (LAI) antipsychotics are an effective option in schizophrenia that increase treatment adherence in potentially non-compliant patients.
eren yildizhan +2 more
doaj
This article relates to Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
Tien‐Wei Hsu +2 more
wiley +1 more source
Lurasidone-induced tardive dyskinesia
Lurasidone is a novel atypical antipsychotic with additional antidepressant and pro-cognitive properties. The drug has shown good efficacy in treatment of schizophrenia as well as bipolar disorder.
Shreyas Shrikant Pendharkar +1 more
doaj +1 more source
A case of tardive dyskinesia with paliperidone palmitate
Background: Tardive dyskinesia is a neurological side effect of long term antipsychotics use. Incidence is common and found to be less prevalent with second generation antipsychotics than the first generation antipsychotics.
Philip Kumar Boyanapally +2 more
doaj +1 more source
A case of persistent tardive dyskinesia in bipolar mania
Mr. CK, a 40-year-old Chinese gentleman is a Bipolar I Disorder patient with no history of depressive episodes. He had never achieved full remission and had 3 previous admissions for manic episodes due to poor insight to his illness.
Ong Kheng Yee
doaj +1 more source
Assefa Kumsa, Shimelis Girma, Bezaye Alemu, Liyew Agenagnew Department of Psychiatry, Faculty of Medical Science, Institute of Health, Jimma University, Jimma, EthiopiaCorrespondence: Liyew AgenagnewJimma University, 378, Jimma, EthiopiaTel +251 ...
Kumsa A, Girma S, Alemu B, Agenagnew L
doaj
Trihexyphenidyl triggered hypomania in a bipolar patient
We observed a case of tardive dyskinesia after regular use of low dose chlorpromazine. An anticholinergic agent; trihexyphenidyl (THX) was used to treat the tardive dyskinesia.
Eren Yıldızhan +3 more
doaj +1 more source
ABSTRACT For hemichorea associated with non‐ketotic hyperglycemia, hypoglycemic therapy is the most commonly used and effective treatment modality. However, some patients may still present with residual chorea‐like symptoms after glycemic control. Alternative symptomatic treatments, such as dopamine receptor antagonists or antipsychotics, carry the ...
Yeqing He, Huanqin Li, Qiufu Dai
wiley +1 more source
Antipsychotic medications may reduce or eliminate symptoms of psychosis. They are not a 'cure' for mental illnesses, but can be an effective part of treating mental disorders.
Farah Naz, Erum Shireen
doaj +1 more source

